Genscript Biotech Corporation, a global biotech company, is a leading life sciences research and application service and product provider that applies its proprietary technology to various fields, from basic life sciences research to translational biomedical development, industrial synthetic products, and cell therapeutic solutions. By leveraging its proprietary gene synthesis and other technologies, Genscript has established four major platforms. Firstly, a leading contracted research organization (CRO) platform to provide one-stop solutions to global research communities. Secondly, a contract development and manufacturing organization (CDMO) platform. Thirdly, an industrial synthetic products platform. And fourthly, an integrated global cell therapy platform. In response to the Covid-19 pandemic, Genescript launched cPass, a patented novel assay and the first commercially available kit to specifically detect COVID-19 neutralizing antibodies without the use of live virus.